Compare WRLD & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | WRLD | CBLL |
|---|---|---|
| Founded | 1962 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 840.4M | 726.2M |
| IPO Year | 1994 | 2024 |
| Metric | WRLD | CBLL |
|---|---|---|
| Price | $190.31 | $23.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $23.20 |
| AVG Volume (30 Days) | 79.6K | ★ 408.1K |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 56.93 |
| EPS | ★ 1.33 | N/A |
| Revenue | ★ $585,166,700.00 | $89,063,000.00 |
| Revenue This Year | N/A | $29.57 |
| Revenue Next Year | $6.51 | $28.44 |
| P/E Ratio | $141.56 | ★ N/A |
| Revenue Growth | 3.60 | ★ 36.09 |
| 52 Week Low | $110.00 | $10.85 |
| 52 Week High | $227.68 | $25.33 |
| Indicator | WRLD | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 48.75 | 69.91 |
| Support Level | $177.77 | $16.70 |
| Resistance Level | $198.81 | $24.29 |
| Average True Range (ATR) | 6.07 | 1.03 |
| MACD | -0.24 | 0.37 |
| Stochastic Oscillator | 42.09 | 79.88 |
World Acceptance Corp operates a small-loan consumer finance (installment loan) business. It offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. The Company generally serves individuals with limited access to other sources of consumer credit such as banks, credit unions, other consumer finance businesses and credit card lenders. The Company also offers income tax return preparation services to its loan customers and other individuals. The traditional installment loan industry is a fragmented segment of the consumer lending industry. The Company has one reportable segment: the consumer finance segment.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.